EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --
EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --

iFOREX Cuts First-Half Earnings Estimate to $1.4 Million After Accounts Review

Posted: 17th Sep 2026

iFOREX Financial Trading Holdings Ltd. cut its first-half adjusted EBITDA estimate to about $1.4 million today (Thursday). That is roughly $1 million below the $2.4 million it gave investors less than two months ago.

The London-listed CFD broker said the change came out of the review of its interim accounts. It recorded a higher liability for amounts owed to clients at June 30 than previously booked, along with a related non-cash expense.

For shareholders, it is the second downward revision since a July update that put first-half revenue at about $27 million and adjusted EBITDA at $2.4 million on a reported basis. The company said revenue and net cash at the end of June are unchanged from that update.

Full-Year Range Stays Where August Left It

iFOREX kept its full-year adjusted EBITDA guidance at $0.5 million to $2.5 million. It said the accounting effect had "largely reversed" after the period ended, so the impact on the full year is immaterial.

That range dates from August 19, when the company cut its outlook after July trading income fell 76.8% year over year to about $720,000. It blamed the drop on a joint US-Japan currency intervention on July 30 and 31, which moved the yen against its net client exposure.

The board struck a slightly firmer tone today. It said trading conditions "remain challenging" but that August came in slightly better than it had expected. It gave no August figures.

Chief Executive Itai Sadeh said at the time: "We are disappointed to be issuing this update so soon after our H1 update."

A Short Record as a Listed Company

iFOREX joined the Main Market of the London Stock Exchange on February 25 at 195 pence a share, after pricing the offering after an eight-month delay.

Three weeks later the stock had barely traded, with founder Eyal Carmon holding 58.91% of the shares under a 12-month lock-up. A thin free float means investors have had few price signals to go on as the updates arrived.

iFOREX's numbers were under pressure before the listing. Adjusted EBITDA fell to about $4 million in 2025 from $9.7 million a year earlier, while revenue slipped to $48.8 million from $50.1 million.

The shekel added a separate drag this year. Most of the company's costs are incurred in Israeli shekels but reported in dollars, and the currency's rise opened a $1.8 million gap between first-half EBITDA on a constant-currency and a reported basis, according to the July update.

What Comes Next

The company plans to publish full interim results on September 24, as previously scheduled. It did not quantify the post-period reversal.

Net cash stood at about $12 million at June 30 with no debt. By August 17 it had fallen to roughly $10 million, of which about $4 million is ring-fenced for regulatory requirements, the company said in its August update.

iFOREX Europe is authorized by the Cyprus Securities and Exchange Commission (CySEC), and iFOREX also holds a license from the Financial Services Commission in the British Virgin Islands. It offers CFDs on more than 870 instruments, according to the company.

This article was written by Damian Chmiel at www.financemagnates.com.

Source: Finance Magnates

Follow us on
Website Managed by BuiltByGo
Disclaimer: The information provided on FX Axe is for educational and informational purposes only and should not be construed as financial advice. Trading Foreign Exchange (FX), Contracts for Difference (CFDs), and other leveraged financial products involves a high level of risk and may not be suitable for all investors. Leverage can work both to your advantage and disadvantage, and as a result, you may lose more than your initial investment. Before deciding to trade FX, CFDs, or any other financial instrument, you should carefully consider your investment objectives, level of experience, and risk tolerance. You should not invest money that you cannot afford to lose. It is strongly advised that you seek independent financial advice if you have any doubts. FX Axe does not provide investment, tax, legal, or financial advice of any kind. We may receive compensation from brokers and partners featured on this website, but such relationships do not influence our reviews or recommendations. All reviews are based on our own opinions and research and should not be interpreted as endorsements or guarantees of any service. Past performance is not indicative of future results. The trading of FX and CFDs carries a significant risk of loss. By using this website, you acknowledge that FX Axe bears no responsibility for any losses you may incur from your trading activities or reliance on information provided here.

Affiliate Disclosure: Some of the links and references on FX Axe may relate to third-party brokers or service providers. In certain cases, we may receive compensation if you choose to engage with these providers through our website. This helps support the ongoing operation of the site and allows us to continue publishing content at no direct cost to our readers. Our content is created with the aim of being informative and useful. While commercial relationships may exist, we strive to ensure that the information presented remains objective and based on our own research and perspective.
cross